AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇨🇮

PERTUZUMAB+TRASTUZUMAB in Côte d'Ivoire

2 products registered with AIRP 2 active

Brand / ProductReg. No.HolderStatusExpires
PHESGO 1200MG/600MG SOLUTION INJECTABLE EN SC FLACON DE 10MLMD/1O0623-0009F. HOFFMANN-LA ROCHE LTDactive23 Oct 2028
PHESGO 600MG/600MG SOLUTION INJECTABLE EN SC FLACON DE 10MLMD/1O0623-0008F. HOFFMANN-LA ROCHE LTDactive23 Oct 2028

PERTUZUMAB+TRASTUZUMABAIRP Registration Details

AIRP (Côte d'Ivoire) has 2 registered products containing PERTUZUMAB+TRASTUZUMAB, of which 2 are currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.

Track PERTUZUMAB+TRASTUZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Pertuzumab Trastuzumab — Côte d'Ivoire (AIRP) | AfricaRegulatory